Malaysia Healthcare Research
41 comprehensive market analysis studies and research reports on the Malaysia Healthcare sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 20000 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Small Molecule Drug Discovery Market
CAGR: 8.76%
Study Period : 2019 - 2030
India Diabetes Devices Market
CAGR: 2.28%
Study Period : 2019 - 2030
Over The Counter Drugs Market
CAGR: 4.80%
Study Period : 2019 - 2030
Japan Veterinary Healthcare Market
CAGR: 6.67%
Study Period : 2019 - 2030
Preclinical Imaging Market
CAGR: 4.71%
Study Period : 2019 - 2030
Healthcare
Categories
41 Healthcare Reports
Categories
Showing 40 of 41 results in Healthcare
Basal Insulin Market
CAGR: 4.70%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Wockhardt
Dipeptide Peptidase 4 Inhibitors Market
CAGR: 2.78%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Eli Lilly and Company
Stereotactic Surgery Services Market
CAGR: 7.5%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Mayo Clinic Care Network, University of Pittsburgh Medical Center (UPMC), Cleveland Clinic Health System, Elekta, MD Anderson Cancer Center
TRENDING REPORTS
Small Molecule Drug Discovery Market
CAGR: 8.76%
Study Period : 2019 - 2030
India Diabetes Devices Market
CAGR: 2.28%
Study Period : 2019 - 2030
Over The Counter Drugs Market
CAGR: 4.80%
Study Period : 2019 - 2030
Japan Veterinary Healthcare Market
CAGR: 6.67%
Study Period : 2019 - 2030
Preclinical Imaging Market
CAGR: 4.71%
Study Period : 2019 - 2030
Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 3.80%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Eli Lilly and Company, Merck, Novartis, Bristol-Myers Squibb
Asia-Pacific Diabetes Drugs Market
CAGR: 2.81%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lilly and Company, Sanofi
Asia-Pacific Continuous Glucose Monitoring Market
CAGR: 11.74%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Dexcom, Medtronic, Abbott Laboratories, Senseonics, Ascensia
Asia-Pacific Self Blood Glucose Monitoring Market
CAGR: 5.5%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:I-Sens, Abbott Laboratories, Ascensia, Lifescan, Roche
Asia-Pacific Insulin Infusion Pumps Market
CAGR: 4.65%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Medtronic, Ypsomed, Insulet, Roche, Tandem Diabetes Care
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 8.35%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb
Asia-Pacific Insulin Therapeutics Market
CAGR: 2.54%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee
Malaysia Diabetes Drugs Market
CAGR: 3.10%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Blood Glucose Test Strips Market
CAGR: 5.96%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Abbott Laboratories, Roche, Lifescan, Arkray, Ascensia Diabetes Care Holdings AG.
Blood Glucose Monitoring Market
CAGR: 7.82%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Medtronic, Dexcom, Lifescan, Abbott Laboratories (Diabetes Care), Roche
Continuous Glucose Monitoring (CGM) Market
CAGR: 16.68%
Study Period: 2021 - 2030
Country Covered: Malaysia
Major Players:Medtronic, Dexcom, Abbott Laboratories, Senseonics, Roche
Asia-Pacific Insulin Syringe Market
CAGR: 0.85%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Beckton Dickinson, Terumo, Nipro, HMD Healthcare, Cardinal Health
Short-acting Insulin Market
CAGR: 3.46%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company, Sanofi, Novo Nordisk, Pfizer, Biocon
Halal Pharmaceuticals Market
CAGR: 12.58%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Greenfield Nutritions, Vitabiotics, Canvita, Zaytun, Vitabiotics
Trulicity Market
CAGR: 10%
Study Period: 2021 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company
Wearable Diabetes Devices Market
CAGR: 10%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Medtronic, Abbott Laboratories, Dexcom, Tandem Diabetes Care, Insulet
Non-Invasive Glucose Monitoring Device Market
CAGR: 8.91%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Abbott Laboratories, Dexcom, Medtronic, Eversence, Nemaura
HbA1c Testing Market
CAGR: 6.13%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Abbott Laboratories, Bio-Rad Laboratories, Roche, Arkray, Beckton Dickinson
Liraglutide Market
CAGR: 3.16%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk
Malaysia Insulin Infusion Pump Market
CAGR: 2.60%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Medtronic, Ascensia, Insulet, Tandem Diabetes Care, Ypsomed
Malaysia Oral Anti-Diabetic Drug Market
CAGR: 3.06%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Astellas Pharma, Eli Lilly and Company, Sanofi, Johnson & Johnson
ASEAN Telehealth Services Market
CAGR: 22.24%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Doctor Anywhere, Halodoc, Aldokter, SeeYouDoc, Viettel
Asia-Pacific Alpha-Glucosidase Inhibitors Market
CAGR: 2.30%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Takeda Pharmaceuticals, Pfizer, Bayer, Sun Pharmaceuticals Industries, Glenmark Pharmaceuticals
APAC Meglitinide Market
CAGR: 1.7%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon
Asia-Pacific Insulin Pens Market
CAGR: 2.70%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Biocon, Wockhardt, Novo Nordisk, Eli Lilly and Company, Sanofi
APAC Biguanide Market
CAGR: 2%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi
Malaysia Diabetes Care Devices Market
CAGR: 4.70%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Medtronic, Roche, Novo Nordisk, Abbott Laboratories, Dexcom
Human Insulin Drugs And Delivery Devices Market
CAGR: 3.73%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk, Sanofi, Eli Lilly and Company, Medtronic, Roche
Asia-Pacific Insulin Delivery Devices Market
CAGR: 2.68%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk, Medtronic, Sanofi, Eli Lilly and Company, Ypsomed
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Combination Anti-Diabetes Drugs Market
CAGR: 10.87%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Boehringer Ingelheim, Sanofi, Merck, Eli Lilly and Company, Novo Nordisk
Alpha-glucosidase Inhibitors Market
CAGR: 2.17%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer
Oral Anti-Diabetic Drugs Market
CAGR: 4.17%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company, Astellas Pharma, Sanofi, Janssen, AstraZeneca
Glucagon-like Peptide-1 (GLP-1) Agonists Market
CAGR: 1.12%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk, Pfizer
Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market
CAGR: 5.38%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Eli Lilly and Company, Novo Nordisk, Sanofi, Biocon
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
